Onesource Specialty Pharma share price

High risk
  • 54%Low risk
  • 54%Moderate risk
  • 54%Balanced risk
  • 54%High risk
  • 54%Extreme risk
  • ₹2,019.10(2.19%)
    June 13, 2025 15:29:50 PM IST
    • NSE
    • BSE
  • Vol : 214.10K (NSE + BSE)
    Last 20 day avg : 281.20 K

Onesource Specialty Pharma is trading 2.19% upper at Rs 2,019.10 as compared to its last closing price. Onesource Specialty Pharma has been trading in the price range of 2,030.00 & 1,805.05. The company posted a net profit of 98.50 Crores in its last quarter.Listed peers of Onesource Specialty Pharma include Emcure Pharmaceuticals (-1.27%), Five Star Business Finance (-2.40%), Onesource Specialty Pharma (2.19%).The Mutual Fund holding in Onesource Specialty Pharma was at 8.32% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Onesource Specialty Pharma was at 18.54% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 13, 2025, 06:55 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    3.85
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.16
    Higher than industry
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,805.05
Highest
2,030.00
52 week range
Lowest
1,163.05
Highest
2,114.95
Onesource Specialty Pharma News
Onesource Specialty Pharma Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsCompany has registered a profit of 98.50 cr vs a loss of 40.17 cr in the same quarter last year.
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Onesource Specialty Pharma Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 2,107.08
  • R2
  • 2,280.72
  • R3
  • 2,446.48
Pivot1,941.32
  • S1
  • 1,767.68
  • S2
  • 1,601.92
  • S3
  • 1,428.28
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Onesource Specialty Pharma Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Emcure Pharmaceuticals
Bullish
1,360.60-1.2725,767.0836.265.69-10.06
Five Star Business Finance
Bullish
767.95-2.4022,840.4720.663.740.25125.65
Onesource Specialty Pharma
Neutral
2,019.102.1923,233.36407.703.94-6.50
Concord Biotech
Bullish
2,115.002.6622,075.4359.1112.120.420.03
Ola Electric Mobility
Bearish
46.97-0.5720,717.67-3.98-39.61
Onesource Specialty Pharma Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Onesource Specialty Pharma is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 20.06% of shares.
    • InsightsPromoter(s) have increased pledged shares to 9.58% from 20.06% earlier.
    • InsightsPromoter(s) holding is moderate at 34.25%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 1.10 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 3.70 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Motilal Oswal Manufacturing Fund Regular Growth
    NA
    • Amount Invested (Cr.) 33.26
    • % of AUM 4.19
    Motilal Oswal Focused Regular Growth
    1/5
    • Amount Invested (Cr.) 61.26
    • % of AUM 3.94
    Motilal Oswal ELSS Tax Saver Fund Regular Plan Growth
    4/5
    • Amount Invested (Cr.) 129.05
    • % of AUM 2.96
    Motilal Oswal Large and Midcap Fund Regular Growth
    4/5
    • Amount Invested (Cr.) 285.61
    • % of AUM 2.63
    Motilal Oswal Balance Advantage Fund Regular Plan Growth Option
    1/5
    • Amount Invested (Cr.) 23.98
    • % of AUM 2.60
    Onesource Specialty Pharma Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-05Audited Results
    2025-01-29Quarterly Results
    About the company Onesource Specialty Pharma
    • Industry
    • ISININE013P01021
    • BSE Code544292
    • NSE CodeBEONESOURCE
    OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
    • Management Info
    • Anurag BhaganiaChief Financial Officer
    • Allada TrishaCompany Secretary, Compliance Officer
    • Neeraj SharmaManaging Director, Executive Director
    Onesource Specialty Pharma Share Price FAQs

    Onesource Specialty Pharma is trading at 2019.10 as on Fri Jun 13 2025 09:59:50. This is 2.19% upper as compared to its previous closing price of 1975.85.

    The market capitalization of Onesource Specialty Pharma is 23233.36 Cr as on Fri Jun 13 2025 09:59:50.

    The 52 wk high for Onesource Specialty Pharma is 2114.95 whereas the 52 wk low is 1163.05

    Onesource Specialty Pharma can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 72.15
    • Dividend Yield: 0.00%
    • D/E ratio: 0.16

    Onesource Specialty Pharma reported a net profit of -17.97 Cr in 2025.

    The Mutual Fund Shareholding was 8.32% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Onesource Specialty Pharma QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Onesource Specialty Pharma share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.